2012;9:1890 5. S7.8-16. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormali- ties: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350 408. S7.8-17. Kumar S, Baldinger SH, Gandjbakhch E, et al. Long-term arrhyth- mic and nonarrhythmic outcomes of lamin A/C mutation carriers. Circulation. 2008;117:e350 408. S7.8-18. Brembilla-Perrot B, Luporsi JD, Louis S, et al. Long-term follow-up of patients with myotonic dystrophy: an electrocardiogram every year is not necessary. Europace. 2011;13:251 7. S7.8-19. Ha AH, Tarnopolsky MA, Bergstra TG, et al. Predictors of atrio- ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II Pacing. Clin Electrophysiol. 2012;35:1262 9. 7.9. Cardiac Channelopathies S7.9-1. Bai R, Napolitano C, Bloise R, et al. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol. 2009;2:6 15. S7.9-2. Goldenberg I, Horr S, Moss AJ, et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syn- drome and normal-range corrected QT intervals. J Am Coll Cardiol. 2011;57:51 9. S7.9-3. Nannenberg EA, Sijbrands EJ, Dijksman LM, et al. Mortality of inher- ited arrhythmia syndromes: insight into their natural history. Circ Cardiovasc Genet. 2012;5:183 9. S7.9-4. Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2012;59:37 45. S7.9-5. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69 74. S7.9-6. 